ViaNautis Bio
PrivateLast Round
Series A
Nov 13, 2023
Total Funding Raised
$27.89M
Company Overview
ViaNautis Bio is a biotechnology company developing a nanomedicine platform to deliver genetic therapies across biological barriers for diseases such as cystic fibrosis and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViaNautis Bio Comparables
Compare ViaNautis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genedit | 88% | |
| Nanite, Inc. | 84% | |
| Deliver Biosciences | 80% | |
ViaNautis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2023 | ||||
| Seed | Mar 29, 2021 |
Key People
Founding team and executive leadership
ViaNautis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A |
| BGF | Series A |
| Origin Capital | Series A, Seed |
| o2h ventures | Series A, Seed |
| 4BIO Capital | Series A |
| Meltwind Advisory | Series A, Seed |
| Cystic Fibrosis Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
Grew 18% QoQ, from 38 to 45 employees.
- Jan 15, 2025
Grew 25% QoQ, from 32 to 40 employees.
ViaNautis Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViaNautis Bio's valuation, stock price, and market status.